Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 2, 2026

A Cell Culture Model for Studying the Role of Neuron-Glia Interactions in Ischemia
11:36

A Cell Culture Model for Studying the Role of Neuron-Glia Interactions in Ischemia

Published on: November 14, 2020

Statins decrease chondroitin sulfate proteoglycan expression and acute astrocyte activation in central nervous system

Eric Holmberg1, Shu-xin Zhang, Patrick D Sarmiere

  • 1Spinal Cord Society Research Center, 2401 Research Boulevard., Suite 206, Fort Collins, CO 80526-1826, USA. eholmberg@scs.cbeyond.com

Experimental Neurology
|August 30, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease Models.

Journal of medicinal chemistry·2026
Same author

IFI204-STING drives protective innate immunity against gangrenous <i>Clostridium perfringens</i> infection via regulation of NLRP3 signaling.

Frontiers in immunology·2026
Same author

Porous organic polymers based on deep-cavity calixarenes for broad-spectrum and high-affinity drug adsorption in the gastrointestinal tract.

Journal of materials chemistry. B·2026
Same author

Deciphering Copper Homeostasis and Cuproptosis: Biological Mechanisms, Disease Connections, and Cutting-Edge Copper-Based Nanomedicine.

Molecular pharmaceutics·2026
Same author

Ruthenium-Catalyzed Solvent-Controlled Chemoselective Asymmetric Hydrogenation of 2,8'-Bisquinoline Derivatives.

Organic letters·2026
Same author

Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease Models.

bioRxiv : the preprint server for biology·2026
Same journal

Opportunities and challenges for the application of single-cell RNA sequencing and spatial transcriptomics in ischemic stroke.

Experimental neurology·2026
Same journal

Behavioral and functional characterization of early-stage Parkinson's disease models reveals attentional deficits and circuit-level connectivity alterations.

Experimental neurology·2026
Same journal

Neuropathological and functional impact of astrocyte-derived extracellular vesicles in an aged model of Alzheimer's disease.

Experimental neurology·2026
Same journal

PI3K/Akt pathway in ischemic stroke: A central regulator of neuronal survival and repair.

Experimental neurology·2026
Same journal

Hepatokines and stellakines in liver and neurological diseases: The liver-brain axis.

Experimental neurology·2026
Same journal

Structural dynamics of α-Synuclein: Multi-scale imaging insights into pathological progression across Synucleinopathies.

Experimental neurology·2026
See all related articles

Statins reduce astrocyte activation and chondroitin sulfate proteoglycan (CSPG) levels in central nervous system (CNS) injuries. While not improving locomotion, these effects suggest statins are promising for CNS injury treatment.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Regenerative Medicine

Background:

  • Statins demonstrate beneficial effects in central nervous system (CNS) injuries.
  • Inhibition of the rhoA/ROCK pathway is one known mechanism of statin action.

Purpose of the Study:

  • To investigate the effect of statins on astrocyte activation and chondroitin sulfate proteoglycan (CSPG) levels in CNS injury models.
  • To explore the potential of statins as a therapeutic agent for CNS injuries.

Main Methods:

  • Administration of simvastatin to astrocyte cultures and animal models of brain stab injury and spinal cord injury (SCI).
  • Quantification of CSPG and glial fibrillary acidic protein (GFAP) levels.
  • Assessment of locomotor function.

Related Experiment Videos

Last Updated: Jul 2, 2026

A Cell Culture Model for Studying the Role of Neuron-Glia Interactions in Ischemia
11:36

A Cell Culture Model for Studying the Role of Neuron-Glia Interactions in Ischemia

Published on: November 14, 2020

Main Results:

  • Simvastatin treatment decreased CSPG levels by up to 45% in astrocyte cultures.
  • In vivo, simvastatin reduced CSPG levels by 60% after brain stab injury and 62-64% after SCI.
  • GFAP levels decreased in brain stab injury models, indicating reduced astrocyte activation.

Conclusions:

  • Statins decrease astrocyte activation and CSPG levels in CNS injury.
  • Reduced astrocyte activation may contribute to CSPG reduction, though other factors are involved.
  • Statins show therapeutic potential for CNS injury despite limited impact on locomotor recovery.